Key result
Sympathetic dysautonomia in CFS links to markedly lower quality of life versus balanced autonomic phenotypes.
Why the study?
The characteristics of autonomic subgroups in patients with Chronic Fatigue Syndrome and their association with illness severity were not well defined.
Population
131 patients with Chronic Fatigue Syndrome (Fukuda criteria)
Comparison
Four autonomic profiles based on cluster analysis of fatigue, autonomic dysfunction, and arterial stiffness factors
Design
Cross-sectional study with symptom assessments and autonomic measurements
Authors
Loading...
Autonomic phenotyping may stratify CFS severity; hypothesis-generating cross-sectional association requires prospective validation before clinical adoption.
Cross-Sectional (n=102)
No
Standardized Mean Difference: 0.8 (95% CI 0.2–1.4)
p-value: p=0.04
Patients with Chronic Fatigue Syndrome can be clustered into distinct autonomic phenotypes, with sympathetic dysautonomia correlating with greater illness severity and lower quality of life.
Słomko et al. (2020) conducted a cross-sectional in Chronic Fatigue Syndrome (n=102). Sympathetic with dysautonomia phenotype vs. Balanced autonomic phenotype was evaluated on Quality of life (Quality of Life Scale) (Cohen's d 0.8, 95% CI 0.2-1.4, p=0.04). In patients with Chronic Fatigue Syndrome, a sympathetic-dysautonomia phenotype was associated with significantly lower quality of life compared to a balanced autonomic phenotype (Cohen's d 0.8).